Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[New developments in oncologic hyperthermia].

C Marchal1

  • 1Département de radiothérapie, centre Alexis-Vautrin, avenue de Bourgogne, 545111 Vandaeuvre-lès-Nancy, France. c.marchal@nancy.fnclcc.fr

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|May 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictive factors of postoperative outcome in the elderly after resective epilepsy surgery.

Revue neurologique·2021
Same author

Severe Lyme neuroborreliosis with bilateral hemorrhagic temporal encephalitis.

Journal of neurology·2020
Same author

[Vagus nerve stimulation for intractable epilepsy: A retrospective bicentric cohort study of 101 patients operated on between 1999 and 2010].

Neuro-Chirurgie·2016
Same author

[Safety and efficacy of whole breast irradiation with a concomitant boost: analysis of 121 cases treated at the Institute of Cancerology of Lorraine].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2014
Same author

Diagnostic methods used to monitor an outbreak of babesiosis (Babesia bovis) in a herd of feral cattle in New Caledonia.

Australian veterinary journal·2013
Same author

Sight-threatening phenylketonuric encephalopathy in a young adult, reversed by diet.

JIMD reports·2013

Hyperthermia (heating tumors) between 40-45°C enhances radiotherapy. Advanced techniques allow deep tumor heating, but France currently lacks clinical application of these deep heating methods.

Area of Science:

  • Oncology
  • Medical Physics
  • Biotechnology

Background:

  • Hyperthermia (40-45°C) is a recognized radiosensitizer, improving local tumor control.
  • Technological advancements enable deep tissue heating with temperature monitoring via open Magnetic Resonance Imaging (MRI).
  • Hyperthermia is standard for cervix carcinomas and sarcomas in Germany and the Netherlands, with ongoing European trials and a proposed network (Eurotherm).

Purpose of the Study:

  • To assess the current status of deep hyperthermia techniques in France.
  • To identify potential French clinical teams for evaluating novel deep heating technologies.
  • To bridge the gap in applying advanced hyperthermia for cancer treatment in France.

Main Methods:

  • Review of current hyperthermia applications in France, including superficial microwave, thermal ablation (radiofrequency, high-intensity focused ultrasound), and regional perfusion.

Related Experiment Videos

  • Analysis of emerging deep heating technologies, such as MRI-guided hyperthermia and thermo-sensitive liposomes for drug/gene delivery.
  • Identification of clinical needs and infrastructure for implementing advanced deep hyperthermia.

    • Main Results:

    • France currently utilizes superficial hyperthermia and thermal ablation, not deep heating techniques.
    • Thermo-sensitive liposomes are being explored in the US for targeted drug and gene delivery via hyperthermia.
    • A disparity exists in the clinical adoption of advanced deep hyperthermia technologies between France and other European countries.

    Conclusions:

    • Deep hyperthermia represents a significant advancement in cancer treatment, enhancing local tumor control.
    • There is a clinical need and opportunity in France to evaluate and adopt advanced deep heating technologies.
    • Establishing clinical collaborations and infrastructure is crucial for integrating these innovative hyperthermia techniques into French cancer care.